Strong margin expansion drives record cash flow from operations and solid ongoing free cash flow of $102 million All amounts ...

Oriola Corporation Stock Exchange Release 29 April 2026 at 8.30 a.m. EEST Oriola Corporation's Interim Report 1 January-31 March 2026 First quarter performance in line with expectations January-March ...

Q4 2025 Earnings Call April 28, 2026 8:00 AM EDTCompany ParticipantsJan Keppeler - Head of Investor Relations, Sustainability ...

Entropy Neurodynamics and LTR Pharma among ASX health companies reporting clinical milestones reached in quarterly results.

OEM Channel 2026 Guidance -- Revenue anticipated as flat to down 5%, in the $61 million to $64.5 million range, with growth in MONOVISC volumes partially offset by lower pricing.

Welcome to Egetis Therapeutics Q1 Report 2026. [Operator Instructions] Now, I will hand the conference over to CEO, Nicklas Westerholm. Please go ahead. Good morning, and a warm welcome to our quarter ...

Revenue uplift in fiscal Q1 2026 was partially attributable to a onetime sales incentive program, creating "short-term ...

Why I am writing this Australia has not lost the need for trained Christian leaders. It has lost alignment in how those ...

The first was at a BCAware conference where security leader Michael Argast delivered a talk on networking. Argast explained ...

Metrolinx previously said announcement of preferred contractor for long-awaited LRT project would come “early” in 2026 - ...

I know it can be irritating to be asked to subscribe to get additional information – especially when you've relied on Moneyweb's free data for years. But the cost of sourcing th ...